Intermediate Susceptibility Dose-Dependent Breakpoints For High Dose Rifampicin, Isoniazid and Pyrazinamide Treatment in multidrug-resistant tuberculosis Programmes.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Zuur, Marlanka APasipanodya, Jotam G
van Soolingen, Dick
van der Werf, Tjip S
Gumbo, Tawanda
Alffenaar, Jan-Willem C
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Intermediate Susceptibility Dose-Dependent Breakpoints For High Dose Rifampicin, Isoniazid and Pyrazinamide Treatment in multidrug-resistant tuberculosis Programmes.Published in
Clin Infect Dis 2018; 67(11):1743-9Publiekssamenvatting
In infectious diseases, for some drugs, bacterial susceptibility is categorized as susceptible, intermediate-susceptible dose-dependent (ISDD), and resistant. The strategy is to use higher doses of first-line agents in the ISDD category, thereby preserving the use of these drugs. This system has not been applied to anti-tuberculosis drugs. Pharmacokinetics/pharmacodynamics (PK/PD) target exposures, in tandem with Monte Carlo experiments (MCE), recently identified susceptibility breakpoints of 0.0312 mg/L for isoniazid, 0.0625 mg/L for rifampicin, and 50 mg/L for pyrazinamide. These have been confirmed in clinical studies.PMID
29697766ae974a485f413a2113503eed53cd6c53
10.1093/cid/ciy346
Scopus Count
Collections
Related articles
- Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
- Authors: Rockwood N, Pasipanodya JG, Denti P, Sirgel F, Lesosky M, Gumbo T, Meintjes G, McIlleron H, Wilkinson RJ
- Issue date: 2017 May 15
- Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
- Authors: Verbeeck RK, Günther G, Kibuule D, Hunter C, Rennie TW
- Issue date: 2016 Aug
- Effect of peritoneal dialysis on plasma and peritoneal fluid concentrations of isoniazid, pyrazinamide, and rifampin.
- Authors: Ahn C, Oh KH, Kim K, Lee KY, Lee JG, Oh MD, Kim Y, Han JS, Kim S, Lee JS, Jang IJ, Shin SG
- Issue date: 2003 Jul-Aug
- Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis.
- Authors: Chigutsa E, Pasipanodya JG, Visser ME, van Helden PD, Smith PJ, Sirgel FA, Gumbo T, McIlleron H
- Issue date: 2015 Jan